1. Home
  2. IMAB vs JUNE Comparison

IMAB vs JUNE Comparison

Compare IMAB & JUNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • JUNE
  • Stock Information
  • Founded
  • IMAB 2014
  • JUNE 1998
  • Country
  • IMAB United States
  • JUNE Hong Kong
  • Employees
  • IMAB N/A
  • JUNE N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • JUNE
  • Sector
  • IMAB Health Care
  • JUNE
  • Exchange
  • IMAB Nasdaq
  • JUNE Nasdaq
  • Market Cap
  • IMAB 83.8M
  • JUNE 67.7M
  • IPO Year
  • IMAB 2020
  • JUNE 2024
  • Fundamental
  • Price
  • IMAB $1.06
  • JUNE $5.00
  • Analyst Decision
  • IMAB Strong Buy
  • JUNE
  • Analyst Count
  • IMAB 3
  • JUNE 0
  • Target Price
  • IMAB $8.00
  • JUNE N/A
  • AVG Volume (30 Days)
  • IMAB 410.6K
  • JUNE 57.1K
  • Earning Date
  • IMAB 08-28-2024
  • JUNE 11-23-2024
  • Dividend Yield
  • IMAB N/A
  • JUNE N/A
  • EPS Growth
  • IMAB N/A
  • JUNE N/A
  • EPS
  • IMAB N/A
  • JUNE N/A
  • Revenue
  • IMAB $3,492,091.00
  • JUNE $2,903,179.00
  • Revenue This Year
  • IMAB N/A
  • JUNE N/A
  • Revenue Next Year
  • IMAB N/A
  • JUNE N/A
  • P/E Ratio
  • IMAB N/A
  • JUNE N/A
  • Revenue Growth
  • IMAB N/A
  • JUNE N/A
  • 52 Week Low
  • IMAB $0.99
  • JUNE $3.60
  • 52 Week High
  • IMAB $2.54
  • JUNE $5.97
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 40.43
  • JUNE N/A
  • Support Level
  • IMAB $1.02
  • JUNE N/A
  • Resistance Level
  • IMAB $1.12
  • JUNE N/A
  • Average True Range (ATR)
  • IMAB 0.08
  • JUNE 0.00
  • MACD
  • IMAB -0.01
  • JUNE 0.00
  • Stochastic Oscillator
  • IMAB 20.00
  • JUNE 0.00

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About JUNE Junee Limited Ordinary Shares

Junee Ltd is a holding company that operates through its subsidiary. It is an interior design and fit-out service provider in Hong Kong. It provides design, fit-out and repair and maintenance services for commercial and residential buildings. The design service includes both the consultation with its staff and the actual design work and it provides a specific conceptualized design with layout plans, detailed design drawings, advice relating to, and other items to be used to produce a preliminary design plan and quotation for clients' considerations. Fit-out works include installing protective materials to cover floors or walls, installing or constructing partition walls, and other electrical and wiring works. Repair and maintenance works include, among other things.

Share on Social Networks: